RxDoctor Payments Data

Vani Dandolu, MD

Urogynecology and Reconstructive Pelvic Surgery · Wilkes Barre, PANPI 1205824224

Payments from drug & device makers

What this record shows

This record is dominated by education: $16,255 of the $22,210 with a category attached, or 73.2%. Intuitive Surgical accounts for 76.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $13,047 and has fallen 99.7% since, to $44 in 2025.

$22,210in general payments, 2019–2025

Across 72 payments — averaging $308.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$17K
  • Caldera Medical, Inc$2K
  • Axonics, Inc.$1K
  • Momentis Surgical Inc.$1K
  • Coloplast$304
  • Urovant Sciences Inc$130
  • plus $431 from 12 others

What the payments were for

  • Consulting fees$1,8218%
  • Travel & lodging$2,31610%
  • Food & beverage$1,8178%
  • Education$16,25573%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,210 in reported general payments places this provider in the 80th percentile of 51 urogynecology and reconstructive pelvic surgery providers in Pennsylvania.

See all urogynecology and reconstructive pelvic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,932
Medicare patients
13
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron20$8,554
Solifenacin Succinate68$5,050
Estradiol43$1,722
Hydrocortisone15$29

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Wilkes Barre

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →